Also listed on Jazz Pharmaceuticals, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Jan 11, 2033 · High confidence
20-year base term ends Jan 11, 2033
Jan 11, 2013
Jan 11, 2033
Jan 17, 2023
This patent's term runs 295 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 2 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 11, 2013, when application 13/739,886, the earliest non-provisional in its chain, was filed (this one was filed May 12, 2020) | Jan 11, 2033 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +295 days, USPTO patent term adjustment record | Nov 2, 2033 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,195,168, US 10,675,258, US 8,591,922, US 8,901,173, US 9,132,107) | capped to Jan 11, 2033 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 11, 2033 | High confidence |
This family
| Application 61/737,695 | Provisional application no patent term | no patent term |
| US 8,591,922 | In force Jan 2033 | Jan 2033 |
| US 9,050,302 | In force Mar 2033 | Mar 2033 |
| US 8,952,029 | In force Mar 2033 | Mar 2033 |
| US 8,772,306 | In force Mar 2033 | Mar 2033 |
| US 9,132,107 | In force Jan 2033 | Jan 2033 |
| Application PCT/US2013/074954 | PCT application no patent term | no patent term |
| US 8,901,173 | In force Jan 2033 | Jan 2033 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 1, 2020 Reel 52805, frame 1 | Allphin, Clark P.; Desjardin, Michael | Jazz Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jun 1, 2020 Reel 52805, frame 249 | Jazz Pharmaceuticals, Inc. | Jazz Pharmaceuticals Ireland Limited | Assignment of Assignor's Interest |
| May 5, 2021 Reel 56151, frame 10 | Cavion, Inc.; Celator Pharmaceuticals, Inc.; Jazz Pharmaceuticals Ireland Limited; Jazz Pharmaceuticals, Inc. | U.S. Bank National Association | Security Agreement |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,195,168, US 10,675,258, US 8,591,922, US 8,901,173, US 9,132,107.